Viracta Initiates Treatment of First Patient in EBV+ Lymphoma Clinical Trial with Tractinostat
Viracta Therapeutics, a clinical-stage drug development company advancing innovative approaches to treat viral-associated cancers and other serious diseases, has init...
Continue Reading →
